Use of risk assessment analysis by failure mode, effects, and criticality to reduce door-to-balloon time

Annals of Emergency Medicine

Volumn 62, Issue 4, 2013, Pages

  Khare, Rahul K ^a   Nannicelli, Anna P ^a   Powell, Emilie S ^a   Seivert, Nicholas P ^a   Adams, James G ^a   Holl, Jane L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL HANDOVER; DOOR TO BALLOON TIME; ELECTROCARDIOGRAM; ELECTRONIC MEDICAL RECORD; HEART CATHETERIZATION; HUMAN; MEDICAID; MEDICAL DOCUMENTATION; MEDICARE; PATIENT ASSESSMENT; PATIENT INFORMATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMUNERATION; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIME; TOTAL QUALITY MANAGEMENT;

EID: 84884501908     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2013.01.023     Document Type: Article

References (69)

1. P.B. Berger, S.G. Ellis, D.R. Holmes Jr Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial Circulation 100 1999 14 20
2. C.P. Cannon, C.M. Gibson, C.T. Lambrew Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 2000 2941 2947
3. R.L. McNamara, Y. Wang, J. Herrin Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 47 2006 2180 2186
4. E.M. Antman, M. Hand, P.W. Armstrong 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 117 2008 296 329
5. Centers for Medicare & Medicaid Services. Federal Register Rules and Regulations 2011 26490 26547 Washington, DC
6. Centers for Medicare & Medicaid Services Frequently asked questions: Hospital Value-Based Purchasing Program http://www.cms.gov/Medicare/Quality- Initiatives-Patient-Assessment-Instruments/hospital-value-based-purchasing/ Downloads/FY-2013-Program-Frequently-Asked-Questions-about-Hospital-VBP-3-9-12. pdf Accessed October 26, 2012
7. E.W. Kelly, J.D. Kelly, B. Hiestand Six Sigma process utilization in reducing door-to-balloon time at a single academic tertiary care center Prog Cardiovasc Dis 53 2010 219 226
8. S.V. Parikh, J.A. Jacobi, E. Chu Treatment delay in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a key process analysis of patient and program factors Am Heart J 155 2008 290 297
9. D. Guss, B. Kress, S. Watson Continuous quality improvement process pin-points delays, speeds STEMI patients to life-saving treatment ED Manag 23 2011 121 124
10. E.H. Bradley, J. Herrin, Y. Wang Strategies for reducing the door-to-balloon time in acute myocardial infarction N Engl J Med 355 2006 2308 2320
11. J.C. Blankenship, K.A. Skelding, T.D. Scott Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial Am J Cardiol 106 2010 1527 1533
12. H.M. Krumholz, J. Herrin, L.E. Miller Improvements in door-to-balloon time in the United States, 2005 to 2010 Circulation 124 2011 1038 1045
13. E. Hollnagel Cognitive Reliability and Error Analysis Method: CREAM 1998 Elsevier New York, NY
14. P. Croskerry Patient Safety in Emergency Medicine 2009 Wolters Kluwer Health/Lippincott Williams & Wilkins Philadelphia, PA
15. G. De Luca, H. Suryapranata, J.P. Ottervanger Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts Circulation 109 2004 1223 1225
16. G. De Luca, A.W. van 't Hof, M.J. de Boer Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty Eur Heart J 25 2004 1009 1013
17. A.W. van 't Hof, A. Liem, H. Suryapranata Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction Eur Heart J 19 1998 118 123
18. B.R. Brodie, T.D. Stuckey, T.C. Wall Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction J Am Coll Cardiol 32 1998 1312 1319
19. B. Nallamothu, K.A. Fox, B.M. Kennelly Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention The Global Registry of Acute Coronary Events Heart 93 2007 1552 1555
20. B.R. Brodie, C. Hansen, T.D. Stuckey Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms J Am Coll Cardiol 47 2006 289 295
21. B.R. Brodie, G.W. Stone, D.A. Cox Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial Am Heart J 151 2006 1231 1238
22. S.S. Rathore, J.P. Curtis, B.K. Nallamothu Association of door-to-balloon time and mortality in patients >65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention Am J Cardiol 104 2009 1198 1203
23. S.S. Rathore, J.P. Curtis, J. Chen Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study BMJ 338 2009 b1807
24. J. DeRosier, E. Stalhandske, J.P. Bagian Using health care failure mode and effect analysis: the VA National Center for Patient Safety & Prospective Risk Analysis System Jt Comm J Qual Improv 28 2002 248 289
25. R.J. Latino, A. Flood Optimizing FMEA and RCA efforts in health care J Healthc Risk Manag 24 2004 21 28
26. J. Burgmeier Failure mode and effect analysis: an application in reducing risk in blood transfusion Jt Comm J Qual Patient Saf 28 2002 331 339
27. D. Robinson, M. Heigham, J. Clark Using failure mode and effects analysis for safe administration of chemotherapy to hospitalized children with cancer Jt Comm J Qual Patient Saf 32 2006 161 166
28. T. Nickerson, M. Jenkins, J. Greenall Using ISMP Canada's framework for failure mode and effects analysis: a tale of two FMEAs Healthc Q 11 3 Spec. No. 2008 40 46
29. R. Esmail, C. Cummings, D. Dersch Using healthcare failure mode and effect analysis tool to review the process of ordering and administering potassium chloride and potassium phosphate Healthc Q 8 2005 73 80
30. M. Apkon, J. Leonard, L. Probst Design of a safer approach to intravenous drug infusions: failure mode effects analysis Qual Saf Health Care 13 2004 265 271
31. D. Kunac, D. Reith Identification of priorities for medication safety in neonatal intensive care Drug Saf 28 2005 251 261
32. C. van Tilburg, I. Leistikow, C. Rademaker Health care failure mode and effect analysis: a useful proactive risk analysis in a paediatric oncology ward Qual Saf Health Care 15 2006 58 64
33. J. Kimehi-Woods, J. Shultz Using HFMEA to assess potential for patient harm from tubing misconnections Jt Comm J Qual Patient Saf 32 2006 373 381
34. S. Saxena, R. Kempf, S. Wilcox Critical laboratory value notification: a failure mode effects and criticality analysis Jt Comm J Qual Patient Saf 31 2005 495 506
35. D. Linkin, C. Sausman, L. Santos Applicability of healthcare failure mode and effects analysis to healthcare epidemiology: evaluation of the sterilization and use of surgical instruments Clin Infect Dis 41 2005 1014 1019
36. J. Kozakiewicz, L. Benis, S. Fisher Safe chemotherapy administration: using failure mode and effects analysis in computerized prescriber order entry Am J Health Syst Pharm 62 2005 1813 1816
37. D.M. Steinberger, S.V. Douglas, M.S. Kirschbaum Use of failure mode and effects analysis for proactive identification of communication and handoff failures from organ procurement to transplantation Prog Transplant 19 2009 208 214
38. M.M. Habraken, T.W. Van der Schaaf, I.P. Leistikow Prospective risk analysis of health care processes: a systematic evaluation of the use of HFMEA in Dutch health care Ergonomics 52 2009 809 819
39. United States Department of Health and Human Services Hospital Compare Web site http://www.medicare.gov/hospitalcompare/ Accessed May 25, 2012
40. E.H. Bradley, S.A. Roumanis, M.J. Radford Achieving door-to-balloon times that meet quality guidelines: how do successful hospitals do it? J Am Coll Cardiol 46 2005 1236 1241
41. D.J. Magid, Y. Wang, J. Herrin Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction JAMA 294 2005 803 812
42. O. Lairez, J. Roncalli, D. Carrié Relationship between time of day, day of the week and in-hospital mortality in patients undergoing emergency percutaneous coronary intervention Arch Cardiovasc Dis 102 2009 811 820
43. B. Maier, S. Behrens, C. Graf-Bothe Time of admission, quality of PCI care, and outcome of patients with ST-elevation myocardial infarction Clin Res Cardiol 99 2010 565 572
44. J.C. Blankenship, K.A. Skelding, T.D. Scott Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial Am J Cardiol 106 2010 1527 1533
45. An introduction to FMEA. Using failure mode and effects analysis to meet JCAHO's proactive risk assessment requirement. Failure modes and effect analysis Health Devices 31 2002 223 226
46. M.L. Chiozza, C. Ponzetti FMEA: a model for reducing medical errors Clin Chim Acta 404 2009 75 78
47. G. Coles, B. Fuller, K. Nordquist Using failure mode effects and criticality analysis for high-risk processes at three community hospitals Jt Comm J Qual Patient Saf 31 2005 132 140
48. S. Day, J. Dalto, J. Fox Failure mode and effects analysis as a performance improvement tool in trauma J Trauma Nurs 13 2006 111 117
49. US Department of Energy DOE-STD-3009-94. Preparation guide for US Department of Energy nonreactor nuclear facility documented safety analyses http://www.hss.doe.gov/nuclearsafety/techstds/docs/standard/doe-std-3009-94-cn3- 3-30-06.pdf Accessed May 25, 2012
50. HNF-8739. Hanford Safety Analysis and Risk Assessment Handbook (SARAH). Richland, WA: Fluor Hanford Inc. Vol Rev.02003.
51. J. Terninko Reliability/mistake-proofing using failure mode and effect analysis American Society for Quality Annual Quality Congress (abstract) 2003 515 526
52. A. Pasquini, S. Pozzi, L. Save A critical view of severity classification in risk assessment methods Reliab Eng Syst Safe 96 2011 53 63
53. D.L. Kunac, D.M. Reith Identification of priorities for medication safety in neonatal intensive care Drug Saf 28 2005 251 261
54. T.B. Wetterneck, K.A. Skibinski, T.L. Roberts Using failure mode and effects analysis to plan implementation of smart iv pump technology Am J Health Syst Pharm 63 2006 1528 1538
55. R.K. Khare, D.M. Courtney, R. Kang The relationship between the emergent primary percutaneous coronary intervention quality measure and inpatient myocardial infarction mortality Acad Emerg Med 17 2010 793 800
56. J. Tobis Impact of 24 hour in-hospital interventional cardiology team on timeliness of reperfusion for STEMI: the challenge of 24-7 on-call for treatment of STEMI Catheter Cardiovasc Interv 75 2010 1024 1025
57. Loyola's on-site cardiology team dramatically improves care for heart attack patients (clinical report) - Medical Devices & Surgical Technology Week http://loyolahealthsystemhere.blogspot.com/2012/09/loyolas-on-site- cardiology-team.html Accessed December 1, 2012
58. On-site cardiology team dramatically improves care for heart attack patients http://www.sciencedaily.com/releases/2011/04/110407171730.htm Accessed May 25, 2012
59. W.E. Deming Out of the Crisis 1986 Massachusetts Institute of Technology, Center for Advanced Engineering Study Cambridge, MA
60. T. Speroff, G.T. O'Connor Study designs for PDSA quality improvement research Qual Manag Health Care 13 2004 17 32
61. G.J. Langley The Improvement Guide: A Practical Approach to Enhancing Organizational Performance 1996 Jossey-Bass Publishers San Francisco, CA
62. A.D. Swain Human reliability analysis: need, status, trends and limitations Reliab Eng Syst Safe 29 1990 301 313
63. E. Hollnagel FRAM: The Functional Resonance Analysis Method: Modelling Complex Socio-Technical Systems 2012 Ashgate Publishing Ltd Farnham, Surrey, Great Britain
64. F. Redmill, J. Rajan Human Factors in Safety-Critical Systems 1997 Butterworth-Heinemann Boston, MA
65. W. Adachi, A.E. Lodolce Use of failure mode and effects analysis in improving the safety of iv drug administration Am J Health Syst Pharm 62 2005 917 920
66. M. Apkon, J. Leonard, L. Probst Design of a safer approach to intravenous drug infusions: failure mode effects analysis Qual Saf Health Care 13 2004 265 271
67. P. Bonnabry, L. Cingria, F. Sadeghipour Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions Qual Saf Health Care 14 2005 93 98
68. Institute for Healthcare Improvement Failure modes and effects analysis (FMEA) tool http://www.ihi.org/knowledge/Pages/Tools/ FailureModesandEffectsAnalysisTool.aspx Accessed December 1, 2012
69. Failure Modes and Effects Analysis in Health Care: Proactive Risk Reduction 2005 Joint Commission Chicago, IL